Revance Therapeutics Inc (DELISTED) (RVNC:DL)
3.65
0.00 (0.00%)
USD |
NASDAQ |
Feb 06, 16:00
Revance Therapeutics Market Cap: 382.89M for Feb. 6, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 79.28B |
| BioAge Labs, Inc. | 686.62M |
| Ligand Pharmaceuticals, Inc. | 4.066B |
| Cellectar Biosciences, Inc. | 6.976M |
| Hepion Pharmaceuticals, Inc. | 0.6410M |
Market Cap Related Metrics
| PS Ratio | 1.374 |
| Price | 3.65 |
| Earnings Yield | -53.15% |